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Summary
The mechanism of bacteriophage DNA injection is
poorly understood, often considered a simple pro-
cess, driven merely by the packing pressure inside
the capsid. In contrast to the well-established DNA
packaging mechanism of 
 
Bacillus subtilis
 
 phage Ø29,
that involves a molecular motor formed by the con-
nector and a viral ATPase, nothing is known about its
DNA injection into the cell. We have studied this pro-
cess measuring DNA binding of p6, a viral genome
organization protein. The linear DNA penetrates with
a right-left polarity, in a two-step process. In the first
step 
 
~
 
65% of the genome is pushed into the cell most
probably by the pressure built inside the viral capsid.
Thus, synthesis of viral proteins from the right early
operon is allowed. This step is controlled, probably by
bacterial protein(s) that slow down DNA entry. In the
second step at least one of the viral early proteins,
p17, participates in the molecular machinery that
pulls the remaining DNA inside the cell. Both steps
are energy-dependent, as treatment of cells with azide
overrides the whole mechanism, leading to a deregu-
lated, passive entry of DNA.
Introduction
 
Bacteriophages are the most abundant group of biological
entities in the biosphere (Bergh 
 
et al
 
., 1989; Danovaro
 
et al
 
., 2001; Rohwer and Edwards, 2002; Rohwer, 2003).
Most phages are host-specific and only infect certain spe-
cies or even strains of bacteria. Bacteriophage infection
follows the same general scheme: the phage first binds
reversibly to the cell surface; then, it recognizes and binds
specifically its receptor, and then DNA is released from
the capsid and injected into the cytoplasm. However,
although a key step in the phage development, we still
have a poor understanding of the molecular mechanisms
of phage infection.
Tailed bacterial viruses are especially efficient in their
ability to infect their hosts, and they are the most studied
ones. A signal has to be transmitted from the receptor
binding site of the tail to the connector or the baseplate,
triggering its opening to allow the DNA ejection. It is gen-
erally believed that the energy required for DNA ejection
from the head is provided mainly by the DNA pressure
built inside the capsid, in which is spooled in a quasi-
crystalline packing (Cerritelli 
 
et al
 
., 1997). However, this
often considered a simple mechanism is far more com-
plex, as there is not a unique way for DNA injection, and
different phages follow different strategies. Thus, in
 
Escherichia coli
 
 phage 
 
l
 
 it is thought that the DNA enters
the cell by diffusion (Filali Maltouf and Labedan, 1985). In
phage T4, that has a contractile tail and a cell-puncturing
device in the baseplate whose structure has recently been
solved at 2.9 Å resolution (Kanamaru 
 
et al
 
., 2002), the
169 kb genome is ejected in 30 s, the highest rate
observed for DNA transport, crossing the cytoplasmic
membrane through ion channels requiring the presence
of the protonmotive force (Boulanger and Letellier, 1988;
Letellier and Boulanger, 1989). However, phage T7, with
a much smaller genome (40 kb) than T4 requires between
9 and 12 min, and is the only system described for which
DNA ejection is coupled to transcription (reviewed in
Molineux, 2001). The initial 850 bp of bacteriophage T7
genome are first delivered into the cytosol by an ejection
mechanism (García and Molineux, 1996) in which it has
been proposed that a molecular motor formed by viral
proteins gp16 and gp15 controls the amount of DNA that
enters the cell (reviewed in Molineux, 2001). The DNA
penetrated includes promoters A1, A2 and A3, recognized
by the 
 
E. coli
 
 RNA polymerase. Then, 
 
E. coli
 
 RNA poly-
merase pulls up to 
 
~
 
7 kb of the T7 genome, that comprise
the T7 RNA polymerase gene and several T7 promoters.
T7 RNA polymerase drags the remainder of the genome
into the cell. Thus, transcription provides the driving force
for the entry of most of the genome; in fact, using laser
tweezers, it has been demonstrated that a transcribing
RNA polymerase is a strong and efficient molecular motor
(Wang 
 
et al
 
., 1998). Phage T5 DNA (121 kb) is transferred
in two steps: 8% of the DNA is first transferred to the
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cytoplasm (Lanni, 1968). Then, there is a pause of about
4 min during which two proteins (A1 and A2) encoded by
this fragment are synthesized. The transfer of the remain-
ing DNA takes place only if these proteins have been
synthesized (reviewed in Letellier 
 
et al
 
., 1999). Although
the mechanism by which they carry out the transfer is not
known, it has been suggested that the DNA binding pro-
tein A2 pulls the DNA (Letellier 
 
et al
 
., 2003).
The non-contractile tail 
 
Bacillus subtilis
 
 phage Ø29 has
a 19 kb linear DNA and has been extensively studied, in
particular its DNA replication and transcription program
(reviewed in Meijer 
 
et al
 
., 2001a), as well as the packaging
mechanism (reviewed in Grimes 
 
et al
 
., 2002). The highly
efficient 
 
in vitro
 
 Ø29 DNA-packaging system has allowed
to understand in great detail this process, in which a rotary
motor translocates unidirectionally the DNA into a pre-
formed capsid precursor called the prohead. This motor
contains three essential components: the connector, the
ATPase and the pRNA. The head-tail connector is a 12-
fold oligomer of protein p10, the structure of which has
been solved by X-ray diffraction (Simpson 
 
et al
 
., 2000;
Guasch 
 
et al
 
., 2002) and suggests a translocation mech-
anism in which the longitudinal displacement of the DNA
along its axis is coupled to connector spinning (Guasch
 
et al
 
., 2002). A more complex model was proposed, imply-
ing a domain displacement within the p10 protomers, and
a spring-like elongation and contraction of the connector
length (Simpson 
 
et al
 
., 2000). Packing of DNA into pro-
heads during morphogenesis is an ATP-driven process,
in which Ø29 protein p16 bears the ATPase activity (Guo
 
et al
 
., 1987a), that requires pRNA (Grimes and Anderson,
1990). The pRNA is a 174 nt RNA coded from the left end
of the genome that forms a ring required for translocation
and probably provides the specificity of the packaging
polarity (Guo 
 
et al
 
., 1987b; for review see Guo, 2002). The
 
in vitro
 
 packaging system has allowed, using optical twee-
zers, to measure the forces involved in the packaging of
a single Ø29 DNA molecule into an isolated prohead,
resulting in one of the strongest molecular motors
reported to date, with an average stalling force of 57 pN
and an initial speed of 100 bases per second under exter-
nal load (Smith 
 
et al
 
., 2001); therefore, the high internal
pressure built up, estimated to be roughly 6 MPa (60
atmospheres), is suggested to provide the driving force
for DNA injection into the host cell for the first half of the
process (Smith 
 
et al
 
., 2001).
The great wealth of data about Ø29 DNA packaging is
in great contrast to the lack of information about the DNA
entry into the host cell. Spontaneous release of Ø29 DNA
from 12
 
–
 
13
 
–
 
 defective viral particles showed a right to left
polarity (Krawiec 
 
et al
 
., 1981). Indeed, the opposite orien-
tation was observed in an 
 
in vitro
 
 DNA packaging system
in which the left end is packaged first (Bjornsti 
 
et al
 
.,
1983). Therefore, it is assumed that the right DNA end
enters the cell first. In this work we have monitored Ø29
DNA entry into the cell by binding of viral protein p6 to the
whole Ø29 DNA 
 
in vivo
 
, analysed by cross-linked chro-
matin immunoprecipitation (X-ChIP) and real-time PCR
(V. González-Huici, unpublished data). We show that Ø29
DNA injection is a finely regulated two-step process. In
the first step the right half of the phage genome gets into
the cell, propelled by the packing pressure of DNA into
the capsid, whereas penetration of the left half requires
synthesis of viral proteins, at least protein p17, and an
external energy source.
 
Results
 
Phage Ø29 DNA injection is a two-step process that 
requires viral protein synthesis
 
Phage Ø29 protein p6 is an architectural protein that
binds along the whole linear Ø29 DNA, although its bind-
ing to both DNA ends is higher than to the internal
regions, being the affinity for the left end higher than for
the right one (V. González-Huici, unpublished data). We
have taken advantage of these features to monitor the
entrance of Ø29 DNA into the host cell during the pro-
cess of viral injection by protein p6 binding. For this, we
have used a 
 
B. subtilis
 
 strain harbouring a plasmid that
constitutively expresses protein p6 (Bravo 
 
et al
 
., 1994)
infected with phage Ø29 
 
sus14
 
(1242), a delayed lysis
mutant (Jiménez 
 
et al
 
., 1977), with otherwise wild-type
phenotype. This p6-producing strain allows a normal
phage development, although the DNA replication onset
and the infective particles production are delayed 15–
20 min (Bravo 
 
et al
 
., 1994; and our unpublished results).
Protein p6 binding to six Ø29 DNA regions was mea-
sured by X-ChIP and real-time PCR. These regions are
scattered through the genome as depicted in Fig. 1A,
where L and R stands for the left and right terminal
regions, respectively, and 5.1, 7.4, 9.7 and 11.7 stands
for their distance (in Kb) from the left end. Infected cells
were treated with novobiocin 10 min before cross-linking,
as it increases the p6 binding by approximately 30-fold
(V. González-Huici, M. Alcorlo, M. Salas and J. M. Her-
moso, in preparation). Table 1 shows protein p6 binding
 
Table 1.
 
Protein p6 binding to Ø29 DNA regions at different times
after infection.
Time (min) L 5.1 7.4 9.7 11.7 R
10 70 124 633 1160 781 2061
20 312 275 1834 2871 2195 4398
30 3065 370 2225 3416 2651 6251
50 68365 3157 8169 9592 7760 30812
Protein p6-producing cells were infected with Ø29 
 
sus14
 
(1242) (moi
3), and cross-linking performed at the times indicated, adding
500 
 
m
 
g ml
 
-
 
1
 
 novobiocin 10 min before. The IC data for the six DNA
regions studied (Fig. 1A) are shown for each infection time.
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to the Ø29 DNA regions, measured at different times
after infection and expressed as immunoprecipitation
coefficient (IC, see 
 
Experimental procedures
 
). As
expected, protein p6 binding at a particular region
increased with the time; furthermore, at any particular
time, except for the last one, the values obtained from the
right end region are higher than those from the left one.
These results clearly show that the polarity of injection is
from right to left. At the latter time, DNA replication is
already started, so p6 binding data are reflecting both
input and replicated DNA. Thus, this latter time cannot be
used for the injection studies.
Interestingly, under these conditions, in protein p6-
producing cells, left end entrance seems to be impaired
with respect to non-producing ones, in which protein p6
is synthesized during infection. When, in these Ø29-
infected cells, we add novobiocin and chloramphenicol
10 min after infection, performing the cross-linking 20 min
after infection, p6 binding at L (IC = 2055) was almost
twice than to R (IC = 1144) (not shown). However, as
shown in Table 1, in p6-producing cells binding to R
(IC = 4398) was more than 10-fold than to L (IC = 312). In
both cases replication has not started, so the data are
comparable. Protein p6 is known to repress transcription
from early promoter C2 (Whiteley 
 
et al
 
., 1986; Barthelemy
 
et al
 
., 1989; Camacho and Salas, 2000) located about
200 bp away of the right end of Ø29 DNA (see Fig. 1A).
Thus, the delay observed in p6-producing cells could be
explained by the repression of promoter C2, suggesting
that one or more proteins coded by this operon could be
involved in injection.
To determine if synthesis of viral proteins is required for
injection of the left end of the Ø29 genome, we infected
p6-producing cells in the presence of chloramphenicol
(CM), performing the cross-link 10 or 40 min later. As
shown in Fig. 1B, again the right to left polarity of infection
is clearly observed. Penetration of the right 
 
~
 
65% of the
genome does not require viral proteins; however, p6 bind-
ing to the left end is negligible even after 40 min post
infection, binding values being about 1% of those to the
right end. This indicates the absolute requirement of newly
synthesized viral protein(s) for injection of the left side of
Ø29 DNA.
To further study the viral protein synthesis requirement,
we added CM at different times after infection. Figure 2
shows that p6 binding to all regions increases with the
 
Fig. 1.
 
Protein p6 binding to Ø29 DNA in the absence of viral 
proteins.
A. Location of the Ø29 DNA regions analysed for protein p6 binding 
in the genetic map of the 19.3 kb linear Ø29 DNA. The sequences 
selected for PCR amplification are shown in black, and the regions 
studied for protein p6 binding, shown in grey, were named L (left end), 
5.1, 7.4, 9.7, 11.7 and R (right end), according to their coordinates. 
Genes (1–17; .5 to .9 stands for genes 16.5–16.9), terminal protein 
(black circles), and main promoters (arrows) are indicated.
B. Protein p6-producing cells were infected with Ø29 mutant 
 
sus14
 
 
(1242) (moi 3), in the presence of 34 
 
m
 
g ml
 
-
 
1
 
 CM and 500 
 
m
 
g ml
 
-
 
1
 
 
novobiocin. Cross-linking was performed 10 (
 

 
 ) or 40 (
 

 
 ) min later. 
The IC data for the six Ø29 DNA regions are plotted versus their 
coordinates (in Kb).
L 5.1 7.4 9.7 11.7 R
0
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Fig. 2.
 
Protein p6 binding to Ø29 DNA after addition of CM at differ-
ent times post infection. Protein p6-producing cells were infected with 
Ø29 mutant 
 
sus14
 
 (1242) (moi 3), and 34 
 
m
 
g ml
 
-
 
1
 
 CM and 500 
 
m
 
g 
ml
 
-
 
1
 
 novobiocin added at infection time (
 

 
) or 5 (
 

 
), 10 (
 

 
), 20 (
 

 
), 
30 (
 

 
) or 40 (
 

 
) min post infection. Cross-linking was performed 
10 min later. The IC values for regions L to R are plotted as in Fig. 1B.
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time, reflecting both the progressive injection of DNA of
adsorbed phages, and the increasing concentration of
protein p6. Although the p6 intrinsic affinity is higher for L
than for R (V. González-Huici, unpublished data), detec-
tion of p6 binding to the left end requires protein synthesis
for 20 min after infection, presumably the time necessary
for the injection protein(s) to reach the minimal intracellu-
lar levels. Protein p6 binding to L only overtakes binding
to R when CM is added 30 min after infection. At this time
we detect a slight increase in the amount of total DNA,
indicating that DNA replication is starting. At the latest
time, binding to L is about twice that to R. This does not
reflect only the infected DNA, as p6 binding data are a
mixture of input and replicated DNA. These results are in
agreement with those shown in Fig. 1B, and confirm the
requirement of viral protein(s) for the entry of the left side
of Ø29 DNA. Under these conditions, in protein p6-pro-
ducing cells, the complete injection of the viral genome
would take at least 30 min, in agreement with the
observed onset of DNA replication 30 min post infection
(not shown).
 
Viral protein p17 is necessary for efficient internalization 
of the left side of Ø29 DNA
 
The injection of the left side of Ø29 DNA requires at least
an early protein expressed from promoter C2, located at
the right side of the genome. Promoter C2 controls an
operon that encodes four gene products: p16.7, p16.8,
p16.9 and p17, of which only p16.7 and p17 have been
studied (reviewed in Meijer 
 
et al
 
., 2001a). Protein p16.7
has been proposed to serve as anchoring point of viral
DNA to the membrane (Meijer 
 
et al
 
., 2000; 2001b; Serna-
Rico 
 
et al
 
., 2002; 2003) and protein p17 has been shown
to be necessary 
 
in vivo
 
 for efficient DNA replication
(Carrascosa 
 
et al
 
., 1976; Crucitti 
 
et al
 
., 1998) and 
 
in vitro
 
enhances the protein p6 binding to DNA (Crucitti 
 
et al
 
.,
2003). To study the possible effect of these proteins in
injection, we followed the viral DNA entrance in p6 pro-
ducing-cells infected with the double mutant Ø29 
 
sus16.7
 
(48)/
 
sus14
 
 (1242) (Meijer 
 
et al
 
., 2001b) and single mutant
Ø29 
 
sus17
 
 (112) (Moreno 
 
et al
 
., 1974), taking as control
the single mutant Ø29 
 
sus14
 
 (1242). Cells were cross-
linked at the indicated times post infection, adding CM and
novobiocin 10 min before, and binding to Ø29 DNA left (L)
and right (R) ends was measured. As shown in Fig. 3A
and B, although the total binding in cells infected with
 
sus16.7
 
(48)/
 
sus14
 
(1242) was lower than in those infected
with 
 
sus14
 
 (1242), the relative binding to L with respect
to R was only barely decreased, being the injection pat-
tern essentially the same in both cases. On the contrary,
the injection pattern changed in Ø29 
 
sus17
 
 (112)-infected
cells, being the binding to L specifically impaired with
respect to R (Fig. 3C). There is an overall lower p6 binding
to both L and R, particularly at late infection times, that
could be the result of the impairment in DNA replication
and protein p6 binding described for this mutant (Crucitti
 
et al
 
., 1998; 2003). The impairment of penetration of L in
 
sus17
 
 (112)-infected cells is more clearly seen in Fig. 3D,
which shows the ratio of p6 binding to L over R for the
three mutants. The L/R binding ratio begins to increase at
25–30 min post infection for 
 
sus14
 
 (1242) and 
 
sus16.7
 
(48)/
 
sus14
 
 (1242), with a slight delay for the latter. How-
ever, the L/R binding ratio for 
 
sus17
 
 (112) begins to
increase at 40–45 min post infection, with a delay of about
15 min with respect to 
 
sus14 
 
(1242) and 
 
sus16.7
 
 (48)/
 
sus14
 
 (1242) mutants. This result indicates that penetra-
tion of the left genome end is impaired in 
 
sus17
 
(112)-
infected cells, therefore protein p17 plays an important
role in the second step of injection. In agreement with this
result, no viral DNA replication is detected in 
 
sus17
 
 (112)-
infected cells at the times analysed, whereas in cells
infected with 
 
sus14
 
 (1242) or 
 
sus16.7
 
 (48)/
 
sus14
 
 (1242)
it is detected 40–45 min post infection (not shown). The
lack of DNA replication has no effect on the L/R binding
ratio, as the same result was essentially obtained with the
replication deficient mutant 
 
sus3
 
 (91) as with 
 
sus14
 
(1242) (not shown).
The requirement of protein p17 for the second step of
Ø29 DNA injection was confirmed by an entirely different
experimental approach: the determination of the kinetic of
synthesis of proteins from the right and left sides of the
genome. Gene 
 
16.7
 
 is transcribed from promoter C2, at
the right genome end, and is injected in the first step.
Gene 
 
6
 
 is on the left operon, transcribed from promoters
A2b and A2c (position 
 
~
 
5 kb; see Fig. 1A), so it is injected
in the second step. For these experiments we used 
 
B.
subtilis
 
 cells non-producing p6, instead of the p6-produc-
ing strain used in all the other experiments. These cells
were infected with Ø29 sus17 (112), and protein synthesis
was analysed by Western blot 10, 15 and 20 min later. We
used as control the Ø29 sus3 (91) mutant to ensure that,
as with sus17 (112) mutant, no DNA replication takes
place at the times studied. Figure 4 shows that the
amount of protein p6 synthesized in Ø29 sus3 (91)-
infected cells is higher than that from sus17 (112)-infected
cells. Therefore, expression of genes from the left side of
the genome is impaired in a Ø29 sus17 mutant, in agree-
ment with a requirement of protein p17 for the second step
of injection. The higher amount of p16.7 in sus17 (112)-
infected cells with respect to sus3 (91)-infected cells again
reflects the delayed injection of the gene 6-containing left
end. The reduced amount of p6 cannot efficiently repress
the C2 promoter.
The mechanism of DNA injection is energy-dependent
Although the first step of Ø29 DNA injection does not
Injection of phage Ø29 DNA 533
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Fig. 3. Protein p6 binding to regions L () and R ( ) of Ø29 DNA in Ø29 sus14(1242)–sus16.7(48) and sus17 (112) mutant-infected cells. 
Protein p6-producing cells were infected (moi 3), and 34 mg ml-1 CM and 500 mg ml-1 novobiocin added 10 min before the indicated cross-linking 
times.
A. Infection with sus14 (1242), used as control.
B. Infection with sus16.7 (48)/sus14 (1242).
C. Infection with sus17 (112).
D. Ratio of protein p6 binding to region L over region R of Ø29 DNA in Ø29 sus14 (1242), sus16.7 (48)/sus14 (1242) or sus17 (112)-infected 
cells. Data are taken from A, B and C, and the L/R binding ratio is plotted versus cross-linking time.
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require the synthesis of viral proteins, and apparently
depends only on the release of the potential energy accu-
mulated in the DNA inside the capsid, the second step
could probably require an external energy source. Thus,
we studied p6 binding to Ø29 DNA left end in protein p6-
producing cells infected with Ø29 sus14 (1242) in the
presence of 20 mM sodium azide, that dissipates the
membrane potential and deprives cells of energy. As
shown in Fig. 5A, azide impairs p6 binding to L, indicating
that efficient internalization of the left end indeed requires
energy. To analyse the possible relation of p17 with this
energy requirement we studied the effect of azide in Ø29
sus17 (112)-infected cells. Surprisingly, in this case azide
increased p6 binding to L about sevenfold (Fig. 5B),
reaching a level comparable to that of azide-treated cells
infected with sus14 (1242) 40 min after infection (Fig. 5A).
If p17 is part of a hypothetical molecular motor that con-
trols the injection process at the expense of energy, de-
energization of the cell would override the motor and allow
a passive, uncontrolled DNA entry. When we added azide
at the infection time in the presence of CM, in which, as
shown before, the entry of the left side of DNA is abso-
lutely prevented (see Fig. 1B), binding to L dramatically
increases (Fig. 5C). This effect is comparable to that
observed in Ø29 sus17 (112)-infected cells and again the
blockage of the entrance of the left part of the DNA is
bypassed, allowing a deregulated, passive injection.
We also studied whether addition of azide has any
effect on the first step of injection, when no viral proteins
are involved. Curiously enough, we found an increase of
p6 binding to the right end of DNA in sus14 (1242)-
infected cells, either at 10 or 40 min post infection
(Fig. 5D), suggesting the existence of an energy-
dependent bacterial mechanism that regulates the pene-
tration of the right end of DNA. Altogether, these results
strongly suggest that both steps of Ø29 DNA injection are
regulated by a protein network that requires energy and
is disabled by de-energization of cells, allowing a passive
and less efficient DNA entry.
Discussion
In this paper we have studied the process of injection of
bacteriophage Ø29 DNA, monitoring the viral DNA
entrance by the binding of protein p6, that organizes the
Ø29 genome in vivo (V. González-Huici, unpublished
data). Protein p6 binding was measured by X-ChIP and
the immunoprecipitated DNA quantified by real-time PCR;
thus, the amount of a particular region of Ø29 DNA inside
the cell can be accurately measured. With this approach
we have determined that the polarity of the viral DNA
penetration is from right to left, in agreement with the
packaging studies that show an inverse polarity (Bjornsti
et al., 1983). Furthermore, we have found that the injec-
tion of Ø29 DNA is a two-step process: the right side
would enter first at the expense of the packaging pressure
of DNA in the capsid, whereas entrance of the left hand
side, prevented by CM, would require viral protein(s).
These results are in agreement with recent studies of Ø29
DNA packaging in vitro using optical tweezers, which
demonstrate that up to ~40% of DNA can be packaged at
a very low energy cost; however, from this point on, the
force necessary to drive DNA into the capsid grows expo-
nentially (Smith et al., 2001). When we add CM after infec-
tion, the amount of injected left end increases with the
time allowed for protein synthesis, until 40 min when the
p6 binding follows the same pattern as in the absence of
CM (V. González-Huici, unpublished data). The protein(s)
involved in the second step of injection are likely synthe-
sized from the C2 operon, located at the very right end of
the viral genome (see Fig. 1A), as C2 is the main early
promoter available to B. subtilis RNA polymerase at the
right Ø29 DNA end. As promoter C2 is repressed in vivo
by protein p6 (Whiteley et al., 1986), completion of the
Fig. 4. Synthesis of proteins p6 and p16.7 in 
cells non-producing p6 infected with Ø29 
mutants sus3 (91) or sus17 (112). Samples 
were taken 10, 15 and 20 min post infection 
(moi 10) and analysed by Western blot. The 
values of densitometric scans (arbitrary units) 
of protein bands are given below.
Injection of phage Ø29 DNA 535
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 529–540
Fig. 5. Effect of azide in protein p6 binding to Ø29 DNA regions L () and R ( ) in sus14 (1242) (A, C, D) or sus17 (112) (B) mutant-infected 
cells. Protein p6-producing cells were infected (moi 3), and 20 mM sodium azide was added at the infection time where indicated. CM 
(34 mg ml-1) and novobiocin (500 mg ml-1) were added at the indicated times. Cross-linking was performed at the indicated infection times.
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injection process is delayed in p6-producing cells at least
20 min with respect to a non-producing strain. In agree-
ment with this, as the genes of the main replication pro-
teins are transcribed from the early promoters A2b and
A2c, located at 5.1 kb from the left end (see Fig. 1A), the
DNA replication onset, as measured by real-time PCR, is
also delayed 20 min in cells that express protein p6 (M.
Alcorlo, unpublished data).
The injection apparatus should include at least one
protein from the right C2 operon that expresses proteins
p16.7, p16.8, p16.9 and p17 (Meijer et al., 2001a). Protein
p17, described to be required for efficient viral DNA syn-
thesis in vivo (Crucitti et al., 1998), plays a central role in
the second step of the injection process. First, in cells
infected with a sus mutant in gene 17 protein p6 binding
to the left end is drastically decreased. As the absence of
protein p17 has no effect on the intrinsic affinity of p6 for
the left end relative to the right one, this result can be
explained only by a delayed penetration of the left end.
Second, the synthesis of proteins from the left operon
(e.g. p6), with respect to those from the right operon (e.g.
p16.7) at early infection times is clearly reduced in sus17
(112)-infected cells in comparison with sus3 (91)-infected
cells. However, other viral proteins, in addition to p17,
seem to be required for an efficient injection. Although the
penetration of the left part of the genome is highly
impaired in a sus17 (112)-infected cell, it is still higher than
that of CM-treated cells, in which no injection of the left
end can be detected. In addition, it is higher when sus17
(112) mutant phage infects a cell non-producing p6 than
a p6-producing one, in which the C2 promoter is
repressed. Protein p16.7, proposed to anchor Ø29 DNA
to the membrane and organize its replication (Serna-Rico
et al., 2003) does not seem to be involved, as the
observed injection delay in sus16.7 (48)-infected cells is
very small. Thus, proteins p16.8 and p16.9, whose func-
tion is still unknown, arise as potential candidates to take
part in the injection machinery that would pull the left side
of Ø29 DNA into the cytoplasm. A model of the Ø29 DNA
injection mechanism is outlined in Fig. 6.
The two-step mechanism of injection allows us to envis-
age a scenario in which Ø29 DNA is transcribed in three
stages: very early, early and late. In the very early tran-
scription, when only the right side of Ø29 DNA is injected,
promoter C2 is the main viral promoter available for the
host RNA polymerase, allowing the synthesis of proteins,
such as p17, involved in pulling the left side of DNA into
the cell. In the early transcription, the injection is com-
pleted and the left early operon is transcribed from pro-
moters A2b and A2c, giving rise to the main replication
proteins, DNA polymerase (p2), terminal protein (p3),
SSB (p5) and p6 (Fig. 1A). The latter, besides its role in
DNA replication, switches off very early transcription from
promoter C2 (Whiteley et al., 1986; Barthelemy et al.,
1989). Late transcription begins when a sufficient amount
of proteins p6 and p4, both transcribed from the early
promoters A2b and A2c, is attained; then, they inhibit early
transcription from pA2b and A2c and trigger transcription
from the late promoter A3 (Elías-Arnanz and Salas, 1999)
giving rise to structural, morphogenetic, and lytic proteins
(Fig. 1A).
We have studied the energetic requirements for Ø29
DNA injection measuring p6 binding to both DNA ends in
cells infected in the presence of azide, showing that both
steps of injection are energy-dependent. Addition of azide
enhanced the first step, suggesting the existence of pro-
tein(s) that control the entry of the right end. These pro-
teins would most probably be bacterial, as no viral
proteins have been described to be delivered into the cell
together with DNA, except the covalently linked terminal
protein; however, we can not rule out that any structural
protein of the phage is involved. DNA injection of phages,
such as T1, T4, T5 and T7, is described to increase the
membrane permeability (Boulanger and Letellier, 1988;
1992; Letellier and Boulanger, 1989). Therefore, it is pre-
sumable that Ø29 DNA enters the cell through a channel
formed by host proteins. Although more data are required
to elucidate the injection mechanism, the simplest model
is that the penetration of the right part of the Ø29 genome,
driven by its high internal force in the virion (~50 pN; Smith
et al., 2001), could be slowed down by a narrowing of the
channel, regulated by a proton-motive force and/or ATP
hydrolysis. Alternatively, there could be a cytoplasmic bac-
terial protein that would clamp the DNA at the expense of
energy. In any case, this controlled entry may be relevant
to optimize expression levels of the C2 operon proteins.
In energy-deprived cells the control of DNA entry would
be prevented, leading to a deregulated penetration of Ø29
DNA. In the case of E. coli phage T5, that also injects its
DNA in two steps, depletion of metabolic energy does not
affect first-step transfer (Filali Maltouf and Labedan,
1983). However, in the case of phage T4 the channel is
closed and DNA penetration prevented (Boulanger and
Letellier, 1988).
In contrast, azide significantly impairs the second step
of Ø29 DNA injection. This seems reasonable as the
penetration of the left part of the genome probably
requires a hypothetical energy-consuming molecular
motor to pull the remaining DNA inside the cell, as when
~60% of the genome is ejected from the capsid the inter-
nal force drops to zero (Smith et al., 2001). Viral proteins
of the C2 operon, at least p17, would be constituent of
this hypothetical motor that could be energized by a host
ATPase (no viral enzyme has been described to play this
role), or an electrochemical gradient. As the motor would
not function in energy-deprived cells, the entrance of the
left part of the genome is impaired, but not completely
aborted, suggesting that a passive, less efficient, mecha-
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nism of injection is also possible. However, when the
injection machinery is incomplete, as is the case of sus17
(112)-infected or CM-treated cells, but energy is available,
left DNA end penetration is prevented to a much higher
extent. This means that bacterial protein(s) halt DNA
entry, keeping DNA stalled until the viral proteins required
for injection have been synthesized. When the injection
machinery is disabled through de-energization, DNA trap-
ping, either by a closed channel or by interaction with
other protein(s), would be avoided and therefore the left
end would entry by the passive mechanism. A similar
situation is described for phage T5, although disabling the
injection machinery is not known to be necessary for T5
DNA to enter the cell by a passive mechanism (Boulanger
and Letellier, 1992).
In conclusion, the results presented in this paper indi-
cate that the injection of Ø29 DNA is a two-step process,
apparently controlled by an active transport mechanism
formed by viral and bacterial proteins (see Fig. 6). In the
first step, about 60% of the right side of Ø29 DNA is
pushed into the cytoplasm, most probably by the packag-
ing pressure built inside the capsid. This process would
be probably controlled by an energy-consuming bacterial
system. The internalized DNA exposes the early rightmost
promoter C2 from which proteins involved in the second
step of injection are expressed, among them protein p17.
They would form the machinery that pulls the left part of
the viral DNA into the cytoplasm. If any piece of the motor
is lacking, the entrance of the left part of the DNA is
prevented; however, energy depletion would override the
Fig. 6. Model for bacteriophage Ø29 DNA injection. Scheme of the ‘push–pull’ mechanism of Ø29 DNA entry into the cell. Once the phage 
recognizes its entry site in the membrane (left), pushes about 65% of its rightmost DNA into the cytoplasm at the expense of the packaging 
pressure inside the capsid (middle). Next, expression of the early promoter C2, at the right end of Ø29 DNA, gives rise to at least four proteins, 
p16.7, p16.8, p16.9 and p17. For the second step of injection (right), assembly of a multiprotein complex is required to pull the remaining DNA 
into the cell. Protein p17 (dark ellipse) would be required for this second step, p16.7 (in white) does not seem to participate, and p16.8 and/or 
p16.9 (dotted ellipses) could be involved, although no evidence is still available. If chloramphenicol (CM) is added, no viral proteins are synthesized 
and therefore the second step of the injection is absolutely prevented. Bacterial protein(s) (dotted square), could also be necessary, at least to 
provide the energy required for the process, either from ATP hydrolysis and/or an electrical (Dy) or proton (DpH) gradient (see Text for details).
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control of the injection, allowing DNA to enter the cell by
simple diffusion. The results presented in this paper open
many interesting questions about this hypothetical motor.
The characterization of proteins p16.8 and p16.9 will shed
light on the viral component of the machinery. The deter-
mination of the energy source, an electrochemical poten-
tial or ATP, may be addressed by the use of specific
inhibitors (as uncouplers, ionophores, oligomycin or
arsenate), and may give valuable clues on the bacterial
protein(s) involved in internalization of the left part of the
Ø29 genome.
Experimental procedures
Bacteria, plasmids and phages
We used a B. subtilis 110NA strain (trpC2, spoOA3, su–)
(Moreno et al., 1974), harbouring plasmid pPR55w6, a
pUB110-derivative containing Ø29 gene 6 (Bravo et al.,
1994), except where indicated. Infections were carried out
with phage Ø29 sus14 (1242), a delayed lysis mutant with
an otherwise wild-type phenotype (Jiménez et al., 1977),
sus3 (91) a replication-null mutant, sus17 (112) (Moreno
et al., 1974) or sus16.7 (48)/sus14 (1242) (Meijer et al.,
2001b), replication-defective mutants. Bacteria were grown
in LB broth supplemented with 5 mM MgSO4. Phleomycin,
from Cayla SARL, was added to the medium at a final con-
centration of 0.8 mg ml-1.
Enzymes, drugs and reactives
Micrococcal nuclease was from Amersham Pharmacia Bio-
tech and proteinase K from Boehringer Mannheim. Protein
A-Sepharose CL-4B, lysozyme, RNase A, chloramphenicol
and novobiocin, were from Sigma. Formaldehyde at 37% was
purchased to Calbiochem. Sodium azide was from Merck.
DNAs and oligonucleotides
Proteinase K-digested Ø29 DNA was obtained as described
(Inciarte et al., 1976). The sequences of the oligonucleotides
used for PCR (Isogen) are given below, together with the
coordinates of the DNA sequence they amplify, Ø1 to Ø6; U:
upper strand; L: lower strand.
L: (U-1) 5¢-AAAGTAAGCCCCCACCCTCACATG
(L-259) 5¢-GCCCACATACTTTGTTGATTGG
5.1: (U-4895) 5¢-GATTTCTCTCTGCATCATTTTTGC
(L-5257) 5¢-CAAAATATCTTCGTGTTCTTCTGG
7.4: (U-7255) 5¢-GAAGTAGATGATATTAAGGACGCC
(L-7528) 5¢-CTGACAGAAGACCAAGCACATCGG
9.7: (U-9507) 5¢-CTGACAACATCGGAAATTACAGCG
(L-9820) 5¢-TTGTTGTAAACGTCTCTCTGACCC
11.7: (U-11567) 5¢-GGATTCTCAATGACGGGTTAGA
(L-11778) 5¢-CACATACACAGGAAAACCAGACTC
R: (U-18988) 5¢-AAAGTAGGGTACAGCGACAACATAC
(L-19285) 5¢-AAATAGATTTTCTTTCTTGGCTAC
Cross-linking, immunoprecipitation and DNA amplification
X-ChIP was performed essentially as described (Lin and
Grossman, 1998) with slight modifications. Bacteria were
grown at 30∞C up to 108 cells ml-1 and infected at a multiplicity
of infection (moi) of 3. Chloramphenicol and/or novobiocin
were added at the indicated times, and except where noted,
bacteria were allowed to grow for 10 additional min before
cross-linking. Culture samples, 20 ml each, were treated
directly with 1% formaldehyde, together with 10 mM sodium
phosphate, pH 7.2. After 5 min at room temperature without
shaking, reactions were stopped by addition of 125 mM gly-
cine. Cells were harvested by centrifugation, washed twice
with PBS buffer and resuspended in 1 ml of buffer A (10 mM
Tris-HCl,  pH 8.0,  50 mM  NaCl,  10 mM  EDTA),  with  3 mg
ml-1 lysozyme. Samples were incubated for 30 min at 37∞C
before lysis by addition of 1 ml of 2 ¥ IP buffer (100 mM Tris-
HCl, pH 7.0, 300 mM NaCl, 2% Triton X-100) and 0.1% SDS.
Then, samples were subjected to mild digestion with micro-
coccal nuclease (0.05 U in the presence of 13 mM CaCl2) for
10 min at 37∞C, stopping reactions with 20 mM EDTA. DNA
was sheared to an average size of 750 bp by sonication and
cell debris eliminated by centrifugation. 1/20 of each sample
was kept for total DNA analysis (T sample) and the remaining
was split to immunoprecipitate with either ap6 polyclonal
antibodies (ap6 sample) or preimmune serum (pi sample)
(20 ml each) overnight at 4∞C, followed by incubation for 2.5 h
at 4∞C with 60 ml of a 25% protein A-Sepharose slurry. Com-
plexes were collected by centrifugation and washed twice
with 1 ¥ IP-0.1% SDS buffer, three times with 1 ¥ IP buffer
and twice with TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM
EDTA). The slurry was resuspended in 150 ml of TE buffer
containing 1% SDS to disrupt immune complexes. Total DNA
samples were also brought to a total volume of 150 ml TE
containing 1% SDS. All samples were incubated overnight at
65∞C with shaking to reverse cross-links. Slurry was removed
by centrifugation and the supernatant transferred to a fresh
tube. DNA was purified by phenol:chloroform extraction, eth-
anol-precipitated and finally resuspended in water.
Analysis of DNA samples was performed by real-time PCR
in a Light-Cycler instrument using a ‘Light Cycler-FastStart
DNA Master SYBR Green I’ hot-start reaction mix (Roche).
Although the sequences amplified are 212–363 bp in length,
the results are representative of a much wider region, as the
average size of the DNA fragments that contain these
sequences is 750 bp. This means 750 bp for regions L and
R, at both ends of the genome, and 1200 bp for the internal
regions 5.1–11.7. The data obtained for each region were
interpolated to a standard curve constructed with known
amounts of purified, full-length, Ø29 DNA. The results were
expressed as pg of Ø29 DNA per ml of culture. Binding
values are expressed as immunoprecipitation coefficient or
IC: [(ap6-pi)/T] ¥ 106.
The amplification conditions included a preheating step of
20 min at 95∞C to activate the polymerase, followed by 30
cycles comprising a denaturation step of 15 s at 95∞C for all
regions, a hybridization step of 5 s at 53∞C for regions L and
11.7, 5 s at 50∞C for R, 10 s at 51∞C for 7.4 and 9.7, and 10 s
at 48∞C for 5.1, and an elongation step at 72∞C lasting 15 s
for L and 11.7, 40 s for R, 30 s for 7.4 and 9.7, and 60 s for
5.1. Finally, a melting analysis was performed by continuous
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fluorescence measurement from 65∞C to 95∞C, to check that
a single product was amplified. Primer hybridization to bac-
terial DNA was previously ruled out in a control with unin-
fected cells.
Western blot analysis
Cells were grown at 30∞C to 108 ml-1 and infected. At the time
indicated, 5 ml aliquots were transferred to an ice-cold tube,
concentrated 20-fold in loading buffer (60 mM Tris-HCl,
pH 6.8, 2% SDS, 5% b-mercaptoethanol, 30% glycerol) and
disrupted by sonication. Aliquots of the cell extract were
subjected to SDS-PAGE on a 15% polyacrylamide gel. After
electrophoresis, proteins were transferred using a Mini Trans
Blot apparatus (Bio-Rad) at 100 mA and 4∞C, for 45 min to
detect protein p16.7 and 60 min to detect protein p6. Immo-
bilon-P membranes (Millipore) were probed with either anti-
p16.7 or anti-p6 polyclonal antibodies (diluted 1:2500 and
1:2000, respectively) for 70 min. Then, membranes were
incubated with anti-rabbit horseradish peroxidase-conjugated
antibodies (diluted 1:4000) for 70 min, and the immune com-
plexes detected by ECL detection reagents (Amersham).
Films were scanned and bands subjected to densitometry
using an Image Quant software.
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